Home »

Yuan Capital

 Chinese investors invested $21 million in California biotech firm

yuan-us.jpgA consortium of Chinese and Singapore investors led by Yuan Capital, a Chinese private equity firm, has announced investment of $21million in California biotech firm Eureka Therapeutics.

Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area, focused on the discovery of fully-human antibody drugs for the treatment of cancer. China's Yuan Capital led the round, with participation from Singapore's Majuven and existing investors, including Acorn Campus Ventures, Suma Venture and Harbinger Venture Capital.

To see listing and email addresses of investors from China, check the Chinese Investors Directory

More details follows

More from Yuan Capital ...

|About Us

SinaBeat Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.

|Subscribe to mailing list

Enter your email address:

Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2018     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on Google+  |   SinaBeat on LinkedIn